Patent Assignment
Reel/Frame 068031/0059
Security Interest
Recorded: 2024-07-19
Received: 2024-07-19
Pages: 9
Assignor
ENDO OPERATIONS LIMITED
Executed: 2024-04-23
Assignee
GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
200 WEST STREET, 7TH FLOOR, ATTN: ANGELIQUE GAYLE IB OPS SYNDICATE, NEW YORK, NY, 10282, UNITED STATES
Covered Properties
(29)
Oxytocin Compositions and Methods
Application:
63/616,999 →
Method of Assessing and Treating Cellulite
Application:
18/482,998 →
Isoproterenol Compositions and Methods
Application:
18/475,954 →
Sodium Bicarbonate Injectable Formulation and Methods Thereof
Application:
18/278,153 →
N-Acetylcysteine Compositions and Methods
Application:
18/359,685 →
Process Intermediate in the Purification of Collagenase Drug Substances
Application:
18/169,480 →
Hydralazine Compositions and Methods
Application:
18/146,756 →
N-Acetylcysteine Compositions and Methods
Application:
17/857,587 →
Method of Purifying and Isolating Collagenase
Application:
17/559,782 →
Method of Assessing and Treating Cellulite
Application:
17/461,481 →
Isoproterenol Compositions and Methods
Application:
17/179,078 →
N-Acetylcysteine Compositions and Methods
Application:
17/177,797 →
Phenylephrine Hydrochloride Compositions and Containers
Application:
17/154,516 →
Method of Producing Collagenase
Application:
15/939,231 →
Method of Assessing and Treating Cellulite
Application:
15/909,991 →
Solid Formulations of Liquid Biologically Active Agents
Application:
15/817,907 →
Misuse Preventative, Controlled Release Formulation
Application:
14/305,895 →
Misuse Preventative, Controlled Release Formulation
Application:
14/305,935 →
Misuse Preventative, Controlled Release Formulation
Application:
14/195,813 →
Misuse Preventative, Controlled Release Formulation
Application:
14/195,833 →
Misuse Preventative, Controlled Release Formulation
Application:
13/919,499 →
Misuse Preventative, Controlled Release Formulation
Application:
13/919,476 →
Misuse Preventative, Controlled Release Formulation
Application:
12/639,664 →
Misuse Preventative, Controlled Release Formulation
Application:
12/336,495 →
Bilayer Composition for the Sustained Release of Acetaminophen and Tramadol
Application:
12/252,117 →
Ultrapure 4-Methylpyrazole
Application:
11/279,708 →
Sustained-Release Tramadol Formulations with 24-Hour Efficacy
Application:
11/112,008 →
Controlled-release compositions
Application:
11/111,996 →
Process for the Preparation of Amphiphilic Poly (N-Vinyl-2-Pyrrolidone) Block Copolymers
Application:
10/727,083 →